日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dynamics of a two-patch epidemic model with deterministic/stochastic migration and distributed delays

具有确定性/随机迁移和分布延迟的双斑块流行病模型的动力学

Kang, Ting; Cao, Boqiang; Shi, Zhenfeng; Wang, Qingyun

DNMT3B promotes the progression of pheochromocytoma by mediating the hypermethylation of LRP1B promoter.

DNMT3B 通过介导 LRP1B 启动子的过度甲基化来促进嗜铬细胞瘤的进展

Sun Min, Ma Yanrong, Wan Jing, Zheng Bingli, Shi Zhenfeng, Li Jiuzhi

Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer

PSA密度和MLR联合检测可提高前列腺癌的诊断准确性

Guo, Feng; Maolake, Aerken; Ni, Zecheng; Li, Xun; Liu, Bide; Tang, Zetian; Shi, Zhenfeng; Li, Jiuzhi

18F-PSMA PET/CT and mpMRI: A combined approach for enhanced risk stratification in prostate cancer-a diagnostic accuracy study

18F-PSMA PET/CT 和 mpMRI:联合应用可增强前列腺癌风险分层——一项诊断准确性研究

Aihemaitijiang, Mierzhayiti; Zhu, Haixu; Che, Kangli; Li, Kai; Wumaner, Aikebaier; Li, Shuo; Gong, Hanwei; Shi, Zhenfeng

A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects

过去二十年获批抗生素的全面概述:回顾与展望

Shi, Zhenfeng; Zhang, Jie; Tian, Lei; Xin, Liang; Liang, Chengyuan; Ren, Xiaodong; Li, Min

Integrated analysis of genes encoding ATP-dependent chromatin remodellers identifies CHD7 as a potential target for colorectal cancer therapy

对编码 ATP 依赖性染色质重塑蛋白的基因进行综合分析,确定 CHD7 是结直肠癌治疗的潜在靶点

Xingyan Zhang, Yaoyao Zhou, Zhenyu Shi, Zhenfeng Liu, Hao Chen, Xiaochen Wang, Yiming Cheng, Lishan Xi, Xuanyuan Li, Chunze Zhang, Li Bao, Chenghao Xuan

BZW1 promotes cell proliferation in prostate cancer by regulating TGF-β1/Smad pathway

BZW1通过调控TGF-β1/Smad通路促进前列腺癌细胞增殖。

Shi, Zhenfeng; Xiao, Chutan; Lin, Tengceng; Wu, Jieyin; Li, Ke

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma

Myc 是骨肉瘤的预后生物标志物和潜在治疗靶点

Wenlong Feng, Dylan C Dean, Francis J Hornicek, Dimitrios Spentzos, Robert M Hoffman, Huirong Shi, Zhenfeng Duan

High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer

SMYD3高表达预示着膀胱癌患者预后不良,并通过IGF-1R/AKT/E2F-1正反馈环路促进肿瘤进展。

Wang, Guoliang; Huang, Yi; Yang, Feilong; Tian, Xiaojun; Wang, Kun; Liu, Li; Fan, Yidong; Li, Xiaofeng; Li, Luchao; Shi, Benkang; Hao, Yichang; Xia, Chuanyou; Nie, Qingsheng; Xin, Yue; Shi, Zhenfeng; Ma, Lulin; Xu, Dawei; Liu, Cheng

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer

细胞周期蛋白依赖性激酶 9 (CDK9) 是卵巢癌的新型预后标志物和治疗靶点

Jinglu Wang, Dylan C Dean, Francis J Hornicek, Huirong Shi, Zhenfeng Duan